Log in to save to my catalogue

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10874890

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

About this item

Full title

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

Publisher

New York: Nature Publishing Group US

Journal title

Cancer gene therapy, 2024-02, Vol.31 (2), p.300-310

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Ovarian cancer is the deadliest gynecological malignancy, and accounts for over 150,000 deaths per year worldwide. The high grade serous ovarian carcinoma (HGSC) subtype accounts for almost 70% of ovarian cancers and is the deadliest. HGSC originates in the fimbria of the fallopian tube and disseminates through the peritoneal cavity. HGSC survival...

Alternative Titles

Full title

CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10874890

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10874890

Other Identifiers

ISSN

0929-1903

E-ISSN

1476-5500

DOI

10.1038/s41417-023-00703-1

How to access this item